| MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ... Focus 21 (3), 315-328, 2023 | 674 | 2023 |
| Impulsive responding in alcoholics JM Mitchell, HL Fields, M D'Esposito, CA Boettiger Alcoholism: clinical and experimental research 29 (12), 2158-2169, 2005 | 424 | 2005 |
| Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158Val/Val genotype CA Boettiger, JM Mitchell, VC Tavares, M Robertson, G Joslyn, ... Journal of Neuroscience 27 (52), 14383-14391, 2007 | 413 | 2007 |
| Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine E Valjent, JM Mitchell, MJ Besson, J Caboche, R Maldonado British journal of pharmacology 135 (2), 564-578, 2002 | 359 | 2002 |
| Midbrain dopamine neurons: projection target determines action potential duration and dopamine D2 receptor inhibition EB Margolis, JM Mitchell, J Ishikawa, GO Hjelmstad, HL Fields Journal of Neuroscience 28 (36), 8908-8913, 2008 | 287 | 2008 |
| Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens JM Mitchell, JP O’Neil, M Janabi, SM Marks, WJ Jagust, HL Fields Science translational medicine 4 (116), 116ra6-116ra6, 2012 | 275 | 2012 |
| Varenicline decreases alcohol consumption in heavy-drinking smokers JM Mitchell, CH Teague, AS Kayser, SE Bartlett, HL Fields Psychopharmacology 223, 299-306, 2012 | 214 | 2012 |
| Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine D De Gregorio, A Aguilar-Valles, KH Preller, BD Heifets, M Hibicke, ... Journal of Neuroscience 41 (5), 891-900, 2021 | 176 | 2021 |
| Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study BT Anderson, A Danforth, R Daroff, C Stauffer, E Ekman, G Agin-Liebes, ... EClinicalMedicine 27, 2020 | 172 | 2020 |
| Dopamine, corticostriatal connectivity, and intertemporal choice AS Kayser, DC Allen, A Navarro-Cebrian, JM Mitchell, HL Fields Journal of Neuroscience 32 (27), 9402-9409, 2012 | 155 | 2012 |
| Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice O Valverde, T Mantamadiotis, M Torrecilla, L Ugedo, J Pineda, ... Neuropsychopharmacology 29 (6), 1122-1133, 2004 | 143 | 2004 |
| Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls JM Mitchell, VC Tavares, HL Fields, M D'Esposito, CA Boettiger Neuropsychopharmacology 32 (2), 439-449, 2007 | 122 | 2007 |
| Electronic health record design and implementation for pharmacogenomics: a local perspective JF Peterson, E Bowton, JR Field, M Beller, J Mitchell, J Schildcrout, ... Genetics in Medicine 15 (10), 833-841, 2013 | 118 | 2013 |
| Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function SA Tershner, JM Mitchell, HL Fields Pain 85 (1-2), 153-159, 2000 | 111 | 2000 |
| δ-Opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption EB Margolis, HL Fields, GO Hjelmstad, JM Mitchell Journal of Neuroscience 28 (48), 12672-12681, 2008 | 107 | 2008 |
| A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats JM Mitchell, MT Liang, HL Fields Psychopharmacology 182, 384-392, 2005 | 104 | 2005 |
| A locus and mechanism of action for associative morphine tolerance JM Mitchell, AI Basbaum, HL Fields Nature neuroscience 3 (1), 47-53, 2000 | 103 | 2000 |
| MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial JM Mitchell, M Ot’alora G, B van der Kolk, S Shannon, M Bogenschutz, ... Nature Medicine 29 (10), 2473-2480, 2023 | 97 | 2023 |
| Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network CA Boettiger, EA Kelley, JM Mitchell, M D'Esposito, HL Fields Pharmacology Biochemistry and Behavior 93 (3), 291-299, 2009 | 97 | 2009 |
| Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder JM Mitchell, PA Arcuni, D Weinstein, JD Woolley Journal of addiction medicine 10 (3), 182-189, 2016 | 93 | 2016 |
